• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高脂血症患者实验室数据的临界值]

[Borderline values of laboratory data in patients with hyperlipidemia].

作者信息

Ninomiya K, Maruhama Y

机构信息

1st Department of Internal Medicine, Iwate Medical University, School of Medicine, Morioka.

出版信息

Rinsho Byori. 1993 Jun;41(6):627-31.

PMID:8361027
Abstract

In Japanese, serum cholesterol levels have been increasing. This seems to be due to changes in life style, mainly the increase in dietary fat. Epidemiologic studies in the United States and Europe have shown that patients with hypercholesterolemia have a high risk of ischemic heart disease. Some guidelines for the management of hyperlipidemia have been developed in the United States, Europe, and Japan. The National Cholesterol Education Program (NECP) in the United States divides serum cholesterol level into three grades (desirable: below 200 mg/dl, borderline: between 200 mg/dl and 240 mg/dl, hypercholesterolemia: over 240 mg/dl). Borderline serum cholesterol is also a risk, especially in people complicated by other risk factor(s). As most borderline serum cholesterol seems to be due to polygenic hypercholesterolemia, an attempt to change the diet should be the first recommendation for treatment.

摘要

在日本,血清胆固醇水平一直在上升。这似乎是由于生活方式的改变,主要是饮食中脂肪摄入的增加。美国和欧洲的流行病学研究表明,高胆固醇血症患者患缺血性心脏病的风险很高。美国、欧洲和日本已经制定了一些高脂血症管理指南。美国国家胆固醇教育计划(NECP)将血清胆固醇水平分为三个等级(理想水平:低于200mg/dl,临界水平:200mg/dl至240mg/dl之间,高胆固醇血症:超过240mg/dl)。临界血清胆固醇也是一种风险,尤其是在伴有其他危险因素的人群中。由于大多数临界血清胆固醇似乎是由多基因高胆固醇血症引起的,改变饮食的尝试应该是治疗的首要建议。

相似文献

1
[Borderline values of laboratory data in patients with hyperlipidemia].[高脂血症患者实验室数据的临界值]
Rinsho Byori. 1993 Jun;41(6):627-31.
2
Management of dyslipidemia in adults.
Am Fam Physician. 1998 May 1;57(9):2192-2204, 2207-8.
3
[Classification of hyperlipidemia in a worksite population in Japan using criteria of the U.S. National Cholesterol Education Program].
Nihon Koshu Eisei Zasshi. 1994 May;41(5):466-73.
4
[Guideline for diagnosis and management of hyperlipidemia for prevention of atherosclerosis in Japan].
Nihon Rinsho. 1999 Dec;57(12):2651-6.
5
The National Cholesterol Education program: guidelines and commentaries.
Bol Asoc Med P R. 1990 Nov;82(11):491-5.
6
High serum total cholesterol--an indicator for monitoring cholesterol lowering efforts: U.S. adults, 2005-2006.高血清总胆固醇——监测降低胆固醇成效的一项指标:2005 - 2006年美国成年人情况
NCHS Data Brief. 2007 Dec(2):1-8.
7
[Atherogenic risk factors in children of parents with ischemic heart disease].
An Esp Pediatr. 1993 Jun;38(6):535-41.
8
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.以高密度脂蛋白胆固醇水平低为特征的人群中血脂异常的风险判定
Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7.
9
Normal growth in high-risk hyperlipidemic children and adolescents with dietary intervention.
Prev Med. 1998 Nov-Dec;27(6):775-80. doi: 10.1006/pmed.1998.0356.
10
Effectiveness of diet in hyperlipidemia in renal transplant patients.
Transplant Proc. 2004 May;36(4):889-90. doi: 10.1016/j.transproceed.2004.03.115.